TY - JOUR
T1 - From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials
AU - van Rijn, Jeaphianne P.M.
AU - Martens, Marvin
AU - Ammar, Ammar
AU - Cimpan, Mihaela Roxana
AU - Fessard, Valerie
AU - Hoet, Peter
AU - Jeliazkova, Nina
AU - Murugadoss, Sivakumar
AU - Vinkovic Vrcek, Ivana
AU - Willighagen, Egon L.
N1 - Funding Information:
This research was funded by European Union Horizon 2020 Programme (H2020) under Grant agreement n\u00BA 814425 (RiskGONE), grant agreement n\u00BA 814572 (NanoSolveIT) and Grant agreement n\u00BA 862195 (SbD4Nano).
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Adverse Outcome Pathways (AOPs) have been proposed to facilitate mechanistic understanding of interactions of chemicals/materials with biological systems. Each AOP starts with a molecular initiating event (MIE) and possibly ends with adverse outcome(s) (AOs) via a series of key events (KEs). So far, the interaction of engineered nanomaterials (ENMs) with biomolecules, biomembranes, cells, and biological structures, in general, is not yet fully elucidated. There is also a huge lack of information on which AOPs are ENMs-relevant or -specific, despite numerous published data on toxicological endpoints they trigger, such as oxidative stress and inflammation. We propose to integrate related data and knowledge recently collected. Our approach combines the annotation of nanomaterials and their MIEs with ontology annotation to demonstrate how we can then query AOPs and biological pathway information for these materials. We conclude that a FAIR (Findable, Accessible, Interoperable, Reusable) representation of the ENM-MIE knowledge simplifies integration with other knowledge.
AB - Adverse Outcome Pathways (AOPs) have been proposed to facilitate mechanistic understanding of interactions of chemicals/materials with biological systems. Each AOP starts with a molecular initiating event (MIE) and possibly ends with adverse outcome(s) (AOs) via a series of key events (KEs). So far, the interaction of engineered nanomaterials (ENMs) with biomolecules, biomembranes, cells, and biological structures, in general, is not yet fully elucidated. There is also a huge lack of information on which AOPs are ENMs-relevant or -specific, despite numerous published data on toxicological endpoints they trigger, such as oxidative stress and inflammation. We propose to integrate related data and knowledge recently collected. Our approach combines the annotation of nanomaterials and their MIEs with ontology annotation to demonstrate how we can then query AOPs and biological pathway information for these materials. We conclude that a FAIR (Findable, Accessible, Interoperable, Reusable) representation of the ENM-MIE knowledge simplifies integration with other knowledge.
KW - Adverse outcome pathways
KW - Engineered nanomaterials
KW - Nanosafety
KW - Resource description framework
U2 - 10.1186/s13321-024-00833-0
DO - 10.1186/s13321-024-00833-0
M3 - Article
SN - 1758-2946
VL - 16
JO - Journal of Cheminformatics
JF - Journal of Cheminformatics
IS - 1
M1 - 49
ER -